Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP835961.RA6N-gBJSj0TCbl2gOxwfh2m9y64o7G3Xul-mLGfrrdTk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP835961.RA6N-gBJSj0TCbl2gOxwfh2m9y64o7G3Xul-mLGfrrdTk130_assertion type Assertion NP835961.RA6N-gBJSj0TCbl2gOxwfh2m9y64o7G3Xul-mLGfrrdTk130_head.
- NP835961.RA6N-gBJSj0TCbl2gOxwfh2m9y64o7G3Xul-mLGfrrdTk130_assertion description "[Ectopic expression of FXR in SK-Hep1 cells reduced tumor growth and metastasis potential of corresponding cells and increased the anti-tumor efficacy of FXR agonists, which may be partly mediated via increased NDRG2 expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP835961.RA6N-gBJSj0TCbl2gOxwfh2m9y64o7G3Xul-mLGfrrdTk130_provenance.
- NP835961.RA6N-gBJSj0TCbl2gOxwfh2m9y64o7G3Xul-mLGfrrdTk130_assertion evidence source_evidence_literature NP835961.RA6N-gBJSj0TCbl2gOxwfh2m9y64o7G3Xul-mLGfrrdTk130_provenance.
- NP835961.RA6N-gBJSj0TCbl2gOxwfh2m9y64o7G3Xul-mLGfrrdTk130_assertion SIO_000772 23056173 NP835961.RA6N-gBJSj0TCbl2gOxwfh2m9y64o7G3Xul-mLGfrrdTk130_provenance.
- NP835961.RA6N-gBJSj0TCbl2gOxwfh2m9y64o7G3Xul-mLGfrrdTk130_assertion wasDerivedFrom befree-20140225 NP835961.RA6N-gBJSj0TCbl2gOxwfh2m9y64o7G3Xul-mLGfrrdTk130_provenance.
- NP835961.RA6N-gBJSj0TCbl2gOxwfh2m9y64o7G3Xul-mLGfrrdTk130_assertion wasGeneratedBy ECO_0000203 NP835961.RA6N-gBJSj0TCbl2gOxwfh2m9y64o7G3Xul-mLGfrrdTk130_provenance.